APO Research
Talk to an analyst

APO RESEARCH · REPORT

Brain AI-assisted Diagnosis

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Brain AI-assisted Diagnosis Market Outlook and Growth Opportunities 2026

6 March 2026191 pages

Choose your research edition.

Industry ResearchBrain AI-assisted Diagnosis Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Brain AI-assisted Diagnosis Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Brain AI-assisted Diagnosis Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Brain AI-assisted Diagnosis Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Brain AI-assisted Diagnosis Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Brain AI-assisted Diagnosis market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Brain AI-assisted Diagnosis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Brain AI-assisted Diagnosis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Brain AI-assisted Diagnosis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Brain AI-assisted Diagnosis market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Brain AI-assisted Diagnosis market include Deepwise, NeuMiva, G K Healthcare, Sense Time, United Imaging, Infervision, Shukun, FOSUN AITROX and BioMind, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Brain AI-assisted Diagnosis market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Brain AI-assisted Diagnosis and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Brain AI-assisted Diagnosis revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Brain AI-assisted Diagnosis market.

Brain AI-assisted Diagnosis Segment by Company

Deepwise

NeuMiva

G K Healthcare

Sense Time

United Imaging

Infervision

Shukun

FOSUN AITROX

BioMind

NANO-X

Aikenist

VUNO

Brain AI-assisted Diagnosis Segment by Type

Cloud-based

On-Primes

Brain AI-assisted Diagnosis Segment by Application

Hospital

Clinic

Imaging Center

Brain AI-assisted Diagnosis Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Brain AI-assisted Diagnosis status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Brain AI-assisted Diagnosis key companies, revenue, market share, and recent developments.

3. To split the Brain AI-assisted Diagnosis breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Brain AI-assisted Diagnosis market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Brain AI-assisted Diagnosis significant trends, drivers, influence factors in global and regions.

6. To analyze Brain AI-assisted Diagnosis competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Brain AI-assisted Diagnosis market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Brain AI-assisted Diagnosis and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Brain AI-assisted Diagnosis.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Brain AI-assisted Diagnosis industry.

Chapter 3: Detailed analysis of Brain AI-assisted Diagnosis company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Brain AI-assisted Diagnosis in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Brain AI-assisted Diagnosis in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Brain AI-assisted Diagnosis Industry Trends Table 2. Brain AI-assisted Diagnosis Industry Drivers Table 3. Brain AI-assisted Diagnosis Industry Opportunities and Challenges Table 4. Brain AI-assisted Diagnosis Industry Restraints Table 5. Global Brain AI-assisted Diagnosis Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Brain AI-assisted Diagnosis Revenue Share by Company (2021-2026) Table 7. Global Brain AI-assisted Diagnosis Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Brain AI-assisted Diagnosis Key Company Manufacturing Base & Headquarters Table 9. Global Brain AI-assisted Diagnosis Company, Product Type & Application Table 10. Global Brain AI-assisted Diagnosis Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Brain AI-assisted Diagnosis by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Cloud-based Table 15. Significant Companies of On-Primes Table 16. Global Brain AI-assisted Diagnosis Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Brain AI-assisted Diagnosis Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Brain AI-assisted Diagnosis Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Brain AI-assisted Diagnosis Sales Value Share by Type (2021-2026) Table 20. Global Brain AI-assisted Diagnosis Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Hospital Table 22. Significant Companies of Clinic Table 23. Significant Companies of Imaging Center Table 24. Global Brain AI-assisted Diagnosis Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Brain AI-assisted Diagnosis Sales Value by Application (2021-2026) & (US$ Million) Table 26. Global Brain AI-assisted Diagnosis Sales Value by Application (2027-2032) & (US$ Million) Table 27. Global Brain AI-assisted Diagnosis Sales Value Share by Application (2021-2026) Table 28. Global Brain AI-assisted Diagnosis Sales Value Share by Application (2027-2032) Table 29. Global Brain AI-assisted Diagnosis Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Brain AI-assisted Diagnosis Sales Value by Region (2021-2026) & (US$ Million) Table 31. Global Brain AI-assisted Diagnosis Sales Value Share by Region (2021-2026) Table 32. Global Brain AI-assisted Diagnosis Sales Value by Region (2027-2032) & (US$ Million) Table 33. Global Brain AI-assisted Diagnosis Sales Value Share by Region (2027-2032) Table 34. Global Brain AI-assisted Diagnosis Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Brain AI-assisted Diagnosis Sales Value by Country (2021-2026) & (US$ Million) Table 36. Global Brain AI-assisted Diagnosis Sales Value Market Share by Country (2021-2026) Table 37. Global Brain AI-assisted Diagnosis Sales Value by Country (2027-2032) & (US$ Million) Table 38. Global Brain AI-assisted Diagnosis Sales Value Market Share by Country (2027-2032) Table 39. Deepwise Company Information Table 40. Deepwise Business Overview Table 41. Deepwise Brain AI-assisted Diagnosis Revenue (US$ Million) and Gross Margin (2021-2026) Table 42. Deepwise Brain AI-assisted Diagnosis Product Portfolio Table 43. Deepwise Recent Development Table 44. NeuMiva Company Information Table 45. NeuMiva Business Overview Table 46. NeuMiva Brain AI-assisted Diagnosis Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. NeuMiva Brain AI-assisted Diagnosis Product Portfolio Table 48. NeuMiva Recent Development Table 49. G K Healthcare Company Information Table 50. G K Healthcare Business Overview Table 51. G K Healthcare Brain AI-assisted Diagnosis Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. G K Healthcare Brain AI-assisted Diagnosis Product Portfolio Table 53. G K Healthcare Recent Development Table 54. Sense Time Company Information Table 55. Sense Time Business Overview Table 56. Sense Time Brain AI-assisted Diagnosis Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. Sense Time Brain AI-assisted Diagnosis Product Portfolio Table 58. Sense Time Recent Development Table 59. United Imaging Company Information Table 60. United Imaging Business Overview Table 61. United Imaging Brain AI-assisted Diagnosis Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. United Imaging Brain AI-assisted Diagnosis Product Portfolio Table 63. United Imaging Recent Development Table 64. Infervision Company Information Table 65. Infervision Business Overview Table 66. Infervision Brain AI-assisted Diagnosis Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Infervision Brain AI-assisted Diagnosis Product Portfolio Table 68. Infervision Recent Development Table 69. Shukun Company Information Table 70. Shukun Business Overview Table 71. Shukun Brain AI-assisted Diagnosis Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Shukun Brain AI-assisted Diagnosis Product Portfolio Table 73. Shukun Recent Development Table 74. FOSUN AITROX Company Information Table 75. FOSUN AITROX Business Overview Table 76. FOSUN AITROX Brain AI-assisted Diagnosis Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. FOSUN AITROX Brain AI-assisted Diagnosis Product Portfolio Table 78. FOSUN AITROX Recent Development Table 79. BioMind Company Information Table 80. BioMind Business Overview Table 81. BioMind Brain AI-assisted Diagnosis Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. BioMind Brain AI-assisted Diagnosis Product Portfolio Table 83. BioMind Recent Development Table 84. NANO-X Company Information Table 85. NANO-X Business Overview Table 86. NANO-X Brain AI-assisted Diagnosis Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. NANO-X Brain AI-assisted Diagnosis Product Portfolio Table 88. NANO-X Recent Development Table 89. Aikenist Company Information Table 90. Aikenist Business Overview Table 91. Aikenist Brain AI-assisted Diagnosis Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 92. Aikenist Brain AI-assisted Diagnosis Product Portfolio Table 93. Aikenist Recent Development Table 94. VUNO Company Information Table 95. VUNO Business Overview Table 96. VUNO Brain AI-assisted Diagnosis Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 97. VUNO Brain AI-assisted Diagnosis Product Portfolio Table 98. VUNO Recent Development Table 99. Research Programs/Design for This Report Table 100. Authors List of This Report Table 101. Secondary Sources Table 102. Primary Sources List of Figures Figure 1. Brain AI-assisted Diagnosis Product Image Figure 2. Global Brain AI-assisted Diagnosis Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Brain AI-assisted Diagnosis Market Size (2021-2032) & (US$ Million) Figure 4. Global Brain AI-assisted Diagnosis Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Cloud-based Image Figure 8. On-Primes Image Figure 9. Global Brain AI-assisted Diagnosis Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Brain AI-assisted Diagnosis Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Brain AI-assisted Diagnosis Sales Value Share by Type (2021-2032) Figure 12. Hospital Image Figure 13. Clinic Image Figure 14. Imaging Center Image Figure 15. Global Brain AI-assisted Diagnosis Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Brain AI-assisted Diagnosis Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Brain AI-assisted Diagnosis Sales Value Share by Application (2021-2032) Figure 18. Global Brain AI-assisted Diagnosis Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Brain AI-assisted Diagnosis Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 20. North America Brain AI-assisted Diagnosis Sales Value (2021-2032) & (US$ Million) Figure 21. North America Brain AI-assisted Diagnosis Sales Value Share by Country (%), 2025 VS 2032 Figure 22. Europe Brain AI-assisted Diagnosis Sales Value (2021-2032) & (US$ Million) Figure 23. Europe Brain AI-assisted Diagnosis Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Asia-Pacific Brain AI-assisted Diagnosis Sales Value (2021-2032) & (US$ Million) Figure 25. Asia-Pacific Brain AI-assisted Diagnosis Sales Value Share by Country (%), 2025 VS 2032 Figure 26. South America Brain AI-assisted Diagnosis Sales Value (2021-2032) & (US$ Million) Figure 27. South America Brain AI-assisted Diagnosis Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Middle East & Africa Brain AI-assisted Diagnosis Sales Value (2021-2032) & (US$ Million) Figure 29. Middle East & Africa Brain AI-assisted Diagnosis Sales Value Share by Country (%), 2025 VS 2032 Figure 30. USA Brain AI-assisted Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 31. USA Brain AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 32. USA Brain AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 33. Canada Brain AI-assisted Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. Canada Brain AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. Canada Brain AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Mexico Brain AI-assisted Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Mexico Brain AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Mexico Brain AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Germany Brain AI-assisted Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Germany Brain AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Germany Brain AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. France Brain AI-assisted Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. France Brain AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. France Brain AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. U.K. Brain AI-assisted Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. U.K. Brain AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. U.K. Brain AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Italy Brain AI-assisted Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Italy Brain AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Italy Brain AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Spain Brain AI-assisted Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Spain Brain AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Spain Brain AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Russia Brain AI-assisted Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Russia Brain AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Russia Brain AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Netherlands Brain AI-assisted Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Netherlands Brain AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Netherlands Brain AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Nordic Countries Brain AI-assisted Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Nordic Countries Brain AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Nordic Countries Brain AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. China Brain AI-assisted Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. China Brain AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. China Brain AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Japan Brain AI-assisted Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Japan Brain AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Japan Brain AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. South Korea Brain AI-assisted Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. South Korea Brain AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. South Korea Brain AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. India Brain AI-assisted Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. India Brain AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. India Brain AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Australia Brain AI-assisted Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Australia Brain AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Australia Brain AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Southeast Asia Brain AI-assisted Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Southeast Asia Brain AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Southeast Asia Brain AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Brazil Brain AI-assisted Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Brazil Brain AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Brazil Brain AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Argentina Brain AI-assisted Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Argentina Brain AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Argentina Brain AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Chile Brain AI-assisted Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Chile Brain AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Chile Brain AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Colombia Brain AI-assisted Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Colombia Brain AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Colombia Brain AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Peru Brain AI-assisted Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Peru Brain AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Peru Brain AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Saudi Arabia Brain AI-assisted Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Saudi Arabia Brain AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Brain AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Israel Brain AI-assisted Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Israel Brain AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Israel Brain AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. UAE Brain AI-assisted Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. UAE Brain AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. UAE Brain AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Turkey Brain AI-assisted Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Turkey Brain AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Turkey Brain AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Iran Brain AI-assisted Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Iran Brain AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Iran Brain AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Egypt Brain AI-assisted Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Egypt Brain AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Egypt Brain AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Years Considered Figure 115. Research Process Figure 116. Key Executives Interviewed

Scope & coverage.

Types
  • Cloud-based
  • On-Primes
Applications
  • Hospital
  • Clinic
  • Imaging Center
Companies covered
  • Deepwise
  • NeuMiva
  • G K Healthcare
  • Sense Time
  • United Imaging
  • Infervision
  • Shukun
  • FOSUN AITROX
  • BioMind
  • NANO-X
  • Aikenist
  • VUNO

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Brain AI-assisted Diagnosis Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Brain AI-assisted Diagnosis Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Brain AI-assisted Diagnosis Market Dynamics
  1. 2.1 Brain AI-assisted Diagnosis Industry Trends
  2. 2.2 Brain AI-assisted Diagnosis Industry Drivers
  3. 2.3 Brain AI-assisted Diagnosis Industry Opportunities and Challenges
  4. 2.4 Brain AI-assisted Diagnosis Industry Restraints
3 Brain AI-assisted Diagnosis Market by Company
  1. 3.1 Global Brain AI-assisted Diagnosis Company Revenue Ranking in 2025
  2. 3.2 Global Brain AI-assisted Diagnosis Revenue by Company (2021-2026)
  3. 3.3 Global Brain AI-assisted Diagnosis Company Ranking (2024-2026)
  4. 3.4 Global Brain AI-assisted Diagnosis Company Manufacturing Base and Headquarters
  5. 3.5 Global Brain AI-assisted Diagnosis Company Product Type and Application
  6. 3.6 Global Brain AI-assisted Diagnosis Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Brain AI-assisted Diagnosis Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Brain AI-assisted Diagnosis Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Brain AI-assisted Diagnosis Market by Type
  1. 4.1 Brain AI-assisted Diagnosis Type Introduction
  2. 4.1.1 Cloud-based
  3. 4.1.2 On-Primes
  4. 4.2 Global Brain AI-assisted Diagnosis Sales Value by Type
  5. 4.2.1 Global Brain AI-assisted Diagnosis Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Brain AI-assisted Diagnosis Sales Value by Type (2021-2032)
  7. 4.2.3 Global Brain AI-assisted Diagnosis Sales Value Share by Type (2021-2032)
5 Brain AI-assisted Diagnosis Market by Application
  1. 5.1 Brain AI-assisted Diagnosis Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Imaging Center
  5. 5.2 Global Brain AI-assisted Diagnosis Sales Value by Application
  6. 5.2.1 Global Brain AI-assisted Diagnosis Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Brain AI-assisted Diagnosis Sales Value by Application (2021-2032)
  8. 5.2.3 Global Brain AI-assisted Diagnosis Sales Value Share by Application (2021-2032)
6 Brain AI-assisted Diagnosis Regional Value Analysis
  1. 6.1 Global Brain AI-assisted Diagnosis Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Brain AI-assisted Diagnosis Sales Value by Region (2021-2032)
  3. 6.2.1 Global Brain AI-assisted Diagnosis Sales Value by Region: 2021-2026
  4. 6.2.2 Global Brain AI-assisted Diagnosis Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Brain AI-assisted Diagnosis Sales Value (2021-2032)
  7. 6.3.2 North America Brain AI-assisted Diagnosis Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Brain AI-assisted Diagnosis Sales Value (2021-2032)
  10. 6.4.2 Europe Brain AI-assisted Diagnosis Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Brain AI-assisted Diagnosis Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Brain AI-assisted Diagnosis Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Brain AI-assisted Diagnosis Sales Value (2021-2032)
  16. 6.6.2 South America Brain AI-assisted Diagnosis Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Brain AI-assisted Diagnosis Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Brain AI-assisted Diagnosis Sales Value Share by Country, 2025 VS 2032
7 Brain AI-assisted Diagnosis Country-level Value Analysis
  1. 7.1 Global Brain AI-assisted Diagnosis Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Brain AI-assisted Diagnosis Sales Value by Country (2021-2032)
  3. 7.2.1 Global Brain AI-assisted Diagnosis Sales Value by Country (2021-2026)
  4. 7.2.2 Global Brain AI-assisted Diagnosis Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Brain AI-assisted Diagnosis Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Brain AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Brain AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Brain AI-assisted Diagnosis Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Brain AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Brain AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Brain AI-assisted Diagnosis Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Brain AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Brain AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Brain AI-assisted Diagnosis Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Brain AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Brain AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Brain AI-assisted Diagnosis Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Brain AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Brain AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Brain AI-assisted Diagnosis Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Brain AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Brain AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Brain AI-assisted Diagnosis Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Brain AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Brain AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Brain AI-assisted Diagnosis Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Brain AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Brain AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Brain AI-assisted Diagnosis Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Brain AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Brain AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Brain AI-assisted Diagnosis Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Brain AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Brain AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Brain AI-assisted Diagnosis Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Brain AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Brain AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Brain AI-assisted Diagnosis Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Brain AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Brain AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Brain AI-assisted Diagnosis Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Brain AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Brain AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Brain AI-assisted Diagnosis Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Brain AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Brain AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Brain AI-assisted Diagnosis Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Brain AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Brain AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Brain AI-assisted Diagnosis Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Brain AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Brain AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Brain AI-assisted Diagnosis Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Brain AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Brain AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Brain AI-assisted Diagnosis Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Brain AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Brain AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Brain AI-assisted Diagnosis Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Brain AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Brain AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Brain AI-assisted Diagnosis Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Brain AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Brain AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Brain AI-assisted Diagnosis Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Brain AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Brain AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Brain AI-assisted Diagnosis Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Brain AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Brain AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Brain AI-assisted Diagnosis Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Brain AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Brain AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Brain AI-assisted Diagnosis Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Brain AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Brain AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Brain AI-assisted Diagnosis Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Brain AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Brain AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Brain AI-assisted Diagnosis Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Brain AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Brain AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Brain AI-assisted Diagnosis Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Brain AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Brain AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Brain AI-assisted Diagnosis Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Brain AI-assisted Diagnosis Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Brain AI-assisted Diagnosis Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Deepwise
  2. 8.1.1 Deepwise Company Information
  3. 8.1.2 Deepwise Business Overview
  4. 8.1.3 Deepwise Brain AI-assisted Diagnosis Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Deepwise Brain AI-assisted Diagnosis Product Portfolio
  6. 8.1.5 Deepwise Recent Developments
  7. 8.2 NeuMiva
  8. 8.2.1 NeuMiva Company Information
  9. 8.2.2 NeuMiva Business Overview
  10. 8.2.3 NeuMiva Brain AI-assisted Diagnosis Revenue and Gross Margin (2021-2026)
  11. 8.2.4 NeuMiva Brain AI-assisted Diagnosis Product Portfolio
  12. 8.2.5 NeuMiva Recent Developments
  13. 8.3 G K Healthcare
  14. 8.3.1 G K Healthcare Company Information
  15. 8.3.2 G K Healthcare Business Overview
  16. 8.3.3 G K Healthcare Brain AI-assisted Diagnosis Revenue and Gross Margin (2021-2026)
  17. 8.3.4 G K Healthcare Brain AI-assisted Diagnosis Product Portfolio
  18. 8.3.5 G K Healthcare Recent Developments
  19. 8.4 Sense Time
  20. 8.4.1 Sense Time Company Information
  21. 8.4.2 Sense Time Business Overview
  22. 8.4.3 Sense Time Brain AI-assisted Diagnosis Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Sense Time Brain AI-assisted Diagnosis Product Portfolio
  24. 8.4.5 Sense Time Recent Developments
  25. 8.5 United Imaging
  26. 8.5.1 United Imaging Company Information
  27. 8.5.2 United Imaging Business Overview
  28. 8.5.3 United Imaging Brain AI-assisted Diagnosis Revenue and Gross Margin (2021-2026)
  29. 8.5.4 United Imaging Brain AI-assisted Diagnosis Product Portfolio
  30. 8.5.5 United Imaging Recent Developments
  31. 8.6 Infervision
  32. 8.6.1 Infervision Company Information
  33. 8.6.2 Infervision Business Overview
  34. 8.6.3 Infervision Brain AI-assisted Diagnosis Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Infervision Brain AI-assisted Diagnosis Product Portfolio
  36. 8.6.5 Infervision Recent Developments
  37. 8.7 Shukun
  38. 8.7.1 Shukun Company Information
  39. 8.7.2 Shukun Business Overview
  40. 8.7.3 Shukun Brain AI-assisted Diagnosis Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Shukun Brain AI-assisted Diagnosis Product Portfolio
  42. 8.7.5 Shukun Recent Developments
  43. 8.8 FOSUN AITROX
  44. 8.8.1 FOSUN AITROX Company Information
  45. 8.8.2 FOSUN AITROX Business Overview
  46. 8.8.3 FOSUN AITROX Brain AI-assisted Diagnosis Revenue and Gross Margin (2021-2026)
  47. 8.8.4 FOSUN AITROX Brain AI-assisted Diagnosis Product Portfolio
  48. 8.8.5 FOSUN AITROX Recent Developments
  49. 8.9 BioMind
  50. 8.9.1 BioMind Company Information
  51. 8.9.2 BioMind Business Overview
  52. 8.9.3 BioMind Brain AI-assisted Diagnosis Revenue and Gross Margin (2021-2026)
  53. 8.9.4 BioMind Brain AI-assisted Diagnosis Product Portfolio
  54. 8.9.5 BioMind Recent Developments
  55. 8.10 NANO-X
  56. 8.10.1 NANO-X Company Information
  57. 8.10.2 NANO-X Business Overview
  58. 8.10.3 NANO-X Brain AI-assisted Diagnosis Revenue and Gross Margin (2021-2026)
  59. 8.10.4 NANO-X Brain AI-assisted Diagnosis Product Portfolio
  60. 8.10.5 NANO-X Recent Developments
  61. 8.11 Aikenist
  62. 8.11.1 Aikenist Company Information
  63. 8.11.2 Aikenist Business Overview
  64. 8.11.3 Aikenist Brain AI-assisted Diagnosis Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Aikenist Brain AI-assisted Diagnosis Product Portfolio
  66. 8.11.5 Aikenist Recent Developments
  67. 8.12 VUNO
  68. 8.12.1 VUNO Company Information
  69. 8.12.2 VUNO Business Overview
  70. 8.12.3 VUNO Brain AI-assisted Diagnosis Revenue and Gross Margin (2021-2026)
  71. 8.12.4 VUNO Brain AI-assisted Diagnosis Product Portfolio
  72. 8.12.5 VUNO Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst